FDA Investigates Fresenius’ Delay in Warning of GranuFlo Danger
The New York Times reports that the FDA is investigating Fresenius, the manufacturer of the recalled dialysis medications GranuFlo and NaturaLyte, to determine whether the company violated federal regulations by waiting four months to warn doctors outside its own network of dialysis centers about the... Read More